Serum IFN-α levels are often elevated in lupus patients [7–9] and the “IFN-α signature” of gene expression in peripheral blood mononuclear cells is present in more than 50% of SLE patients [10–14]. Here, IFNA1 is linked to systemic lupus erythematosus.